2) chemoradiotherapy
同步放化疗
1.
Curative effect of preoperative chemoradiotherapy and radiotherapy for the patients with bulky cervical cancer in early stage;
早期巨块型宫颈癌术前同步放化疗与单纯放疗的近期疗效对比分析
2.
Changes of HPV DNA and TNF-α levels in patients with advanced cervical cancer before and after concurrent chemoradiotherapy;
宫颈癌同步放化疗前后HPV DNA及TNF-α的变化
3.
Value of EGFR and HER2 to predict the sensitivity of chemoradiotherapy in the esophageal squamous cell carcinoma
EGFR,HER2预测食管鳞状细胞癌同步放化疗敏感性的价值
3) Concurrent radiochemotherapy
同步放化疗
1.
Phase Ⅰ trial of postoperative concurrent radiochemotherapy for patients with Ⅰ_(b1)-Ⅱ_b cervical carcinoma;
Ⅰ_(b1)-Ⅱ_b期宫颈癌术后同步放化疗的Ⅰ期临床研究
2.
Standardization of concurrent radiochemotherapy in locally advanced NSCLC
局部晚期非小细胞肺癌同步放化疗规范
3.
Objective To evaluate the effects of megestrol acetate (MA) in protecting marrow, decreasing digestive tract reaction and improving the quality of life in the patients with nasopharyngeal carcinoma(NPC) at stage Ⅱ～Ⅲ treated with concurrent radiochemotherapy.
目的评价甲地孕酮在Ⅱ~Ⅲ期鼻咽癌患者同步放化疗中保护骨髓、减少消化道反应以及改善患者生活质量的作用。
4) Concurrent chemoradiotherapy
同步放化疗
1.
Clinical study on concurrent chemoradiotherapy for locally advanced cervical cancer;
42例局部晚期宫颈癌同步放化疗的临床疗效分析
2.
Dose escalation of nedaplatin combined with floxuridine in concurrent chemoradiotherapy for esophageal carcinoma;
食管癌同步放化疗奈达铂加氟脲苷方案剂量递增试验
3.
Objective To evaluate therapeutic effect and safety of paclitaxel liposome combined with cisplatin for patients with Ⅲ~Ⅳ degrees of cervical cancer in concurrent chemoradiotherapy in absence of pretreatment.
目的观察紫杉醇脂质体未作预处理在同步放化疗治疗中晚期宫颈癌中的疗效及安全性。
5) concurrent chemotherapy and radiotherapy
同步放化疗
1.
In recent years,with the application of chemotherapeutics,the concurrent chemotherapy and radiotherapy and neoadjuvant chemotherapy are increasing.
宫颈癌常规的治疗方法是手术治疗和放疗,近年来,随着化疗药物在临床上的应用,宫颈癌的同步放化疗与新辅助化疗日益增多,本文就其研究进展进行综述。
2.
Methods Eighty-six Ⅲ and Ⅳ stage cervical cancer patients were randomly divided into the induced-chemotherapy(IC) group(43 patients) and the concurrent chemotherapy and radiotherapy(CCR) group(43 patients).
方法86例Ⅲ和Ⅳ期宫颈癌患者用信封法随机分为2组,每组各43例(Ⅲ期各26例,Ⅳ期各17例)一组采用诱导化疗,另一组为同步放化疗,两组放疗方法、时间、剂量和分割均相同。
3.
Objective:To observe the curative effect of hypertherapy with concurrent chemotherapy and radiotherapy in treating the patients with locally advanced cervix cancer.
目的:观察热疗联合同步放化疗对中晚期宫颈癌的疗效。
6) Concurrent radiotherapy and chemotherapy
同步放化疗
1.
Clinical study on concurrent radiotherapy and chemotherapy combined with highly agglutinative ataphglococcin in the treatment of local advanced cervical cancers;
同步放化疗联合高聚金葡素治疗局部晚期宫颈癌的临床观察
2.
Objective: To observe the clinical efficacy and the adverse reactions of concurrent radiotherapy and chemotherapy combined with Amifostine for the patients with cervical and upper thoracic esophageal cancer.
目的:观察颈段及胸上段食管癌同步放化疗配合氨磷汀的临床疗效及不良反应。
补充资料：同步
1.同时起步，协调一致。 2.物理学名词。两个或几个随时间变化的量，在变化过程中保持一定的相对关系。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条